Paris- and Luxembourg-based GP Xerys Funds has invested an additional €30m in France-based Biolog-id, a specialist in traceability and management of sensitive health products.
Previous fund held a final close in 2012 with capital commitments of USD 840m
MoU marks LBO France's first foray into the Chinese market, with plans to open a local office
ECI bought the asset from Phoenix less than three years ago
Silver Lake, CVC, Advent and KKR are already set to join the race, sources say